» Articles » PMID: 28328807

Associations of IL-4, IL-6, and IL-12 Levels in Peripheral Blood with Lung Function, Cellular Immune Function, and Quality of Life in Children with Moderate-to-severe Asthma

Overview
Specialty General Medicine
Date 2017 Mar 23
PMID 28328807
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pediatric asthma has gained increasing concerns with poorly understood pathogenesis. The purpose of this study was to explore the associations of interleukin-4 (IL-4), IL-6, and IL-12 levels in peripheral blood (PB) with lung function, cellular immune function, and children's quality of life (QOL) with moderate-to-severe asthma.

Methods: A total of 1158 children with moderate-to-severe asthma (the experimental group) and 1075 healthy children (the control group) were recruited for our study. Enzyme-linked immunosorbent assay was used to detect IL-4, IL-6, and IL-12 levels. T lymphocytes were detected by alkaline phosphatase antialkaline phosphatase, and erythrocyte immune was measured by red blood cell C 3b receptor (RBC-C3bR) rosette-forming test. The forced expiratory volume in 1 second (FEV1) and peak expiratory flow (PEF) were detected, after which FEV1/forced vital capacity (FVC) was calculated before and after treatment. PedsQL3.0 was used to measure the effect of asthma on QOL of children, and the correlation between IL-4, IL-6, and IL-12 levels and the lung function and QOL was measured. Logistic regression analysis was applied to detect related factors of moderate-to-severe asthma of children.

Results: After treatment, the decreased IL-4 and IL-6 levels and increased IL-12 level were revealed in the experimental group. The cellular immune function's disorder was significantly decreased, and an elevated CD3, CD4, CD8, and declined CD4/CD8 level was performed in T lymphocytes. RBC-C3bR was increased, and red blood cell immune complex (RBC-IC) was reduced in erythrocyte immune in comparison with those before treatment. Lung function parameters all increased. After treatment, the symptoms of asthma in children reduced with scores of increased QOL. IL-4 was positively related to RBC-IC, but negatively associated with the QOL score. IL-6 showed negative connection with CD4/CD8, RBC-C3bR, FEV1/FVC, and QOL score, and had positive connection with PEF. In addition, IL-12 was negatively correlated with PEF. The levels of IL-4, RBC-C3bR, FEV1/FVC, and PEF were independent risk factors for the prognosis of treatment for children with moderate-to-severe asthma.

Conclusion: This study demonstrated that IL-4, IL-6, and IL-12 levels in PB were associated with lung function, cellular immune function, and QOL in children with moderate-to-severe asthma.

Citing Articles

Protective effects of myrtenol against paraquat-induced toxicity in rats.

Amin F, Basirat H, Parvaz N, Khademalhosseini M, Hakimizadeh E, Fatemi I BMC Pulm Med. 2025; 25(1):17.

PMID: 39806385 PMC: 11730473. DOI: 10.1186/s12890-025-03484-5.


Effects of theophylline combined with inhaled corticosteroids on patients with moderate and severe asthma and changes of T lymphocyte subsets in peripheral blood.

Cai X, Rong R, Huang Y, Pu X, Ge N Cent Eur J Immunol. 2023; 48(2):135-143.

PMID: 37692023 PMC: 10485692. DOI: 10.5114/ceji.2023.127843.


Diagnostic value of IL-6 for patients with asthma: a meta-analysis.

Pan R, Kuai S, Li Q, Zhu X, Wang T, Cui Y Allergy Asthma Clin Immunol. 2023; 19(1):39.

PMID: 37173781 PMC: 10182700. DOI: 10.1186/s13223-023-00794-3.


Magnetic nanoparticles enhance the cellular immune response of dendritic cell tumor vaccines by realizing the cytoplasmic delivery of tumor antigens.

Huang L, Liu Z, Wu C, Lin J, Liu N Bioeng Transl Med. 2023; 8(2):e10400.

PMID: 36925683 PMC: 10013825. DOI: 10.1002/btm2.10400.


Profiles and predictive value of cytokines in children with human metapneumovirus pneumonia.

Xiang W, Li L, Wang B, Ali A, Li W Virol J. 2022; 19(1):214.

PMID: 36496397 PMC: 9741804. DOI: 10.1186/s12985-022-01949-1.


References
1.
Rincon M, Irvin C . Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci. 2012; 8(9):1281-90. PMC: 3491451. DOI: 10.7150/ijbs.4874. View

2.
Fu J, McDonald V, Gibson P, Simpson J . Systemic Inflammation in Older Adults With Asthma-COPD Overlap Syndrome. Allergy Asthma Immunol Res. 2014; 6(4):316-24. PMC: 4077958. DOI: 10.4168/aair.2014.6.4.316. View

3.
Kortylewski M, Xin H, Kujawski M, Lee H, Liu Y, Harris T . Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell. 2009; 15(2):114-23. PMC: 2673504. DOI: 10.1016/j.ccr.2008.12.018. View

4.
Dunn R, Wechsler M . Anti-interleukin therapy in asthma. Clin Pharmacol Ther. 2015; 97(1):55-65. DOI: 10.1002/cpt.11. View

5.
Fang S, Tanaka T, Tago F, Okamoto T, Kojima S . Immunomodulatory effects of gyokuheifusan on INF-gamma/IL-4 (Th1/Th2) balance in ovalbumin (OVA)-induced asthma model mice. Biol Pharm Bull. 2005; 28(5):829-33. DOI: 10.1248/bpb.28.829. View